Product Information

POTASSIUM CITRATE ER 15 MEQ TB is a generic product labeled by Strides Pharma Inc., priced at $0.1804 per EA under NDC 42543040801. Its NADAC has been published 465 times since Sep 27, 2017.

FDA first approved this application on Sep 11, 2017. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

POTASSIUM CITRATE ER 15 MEQ TB

POTASSIUM CITRATE
$0.1804per EA

Strength

15 meq/1

NDC

42543040801

Classification

Generic

Dosage Form

TABLET

Route

ORAL

Effective Date

8/19/2026

Active Ingredients

POTASSIUM CITRATE

Approval Type

Generic (ANDA)

FDA Application

ANDA206813

FDA Approved

9/11/2017

TE Code

AB

On Market Since

11/1/2017

Pharmacological Classes

Acidifying Activity
Anti-coagulant
Calcium Chelating Activity
Calculi Dissolution Agent
Decreased Coagulation Factor Activity

Price Statistics

The NADAC for POTASSIUM CITRATE ER 15 MEQ TB has been published 465 times since Sep 27, 2017, and over the history we have for it it has declined 90.2%. The table below summarizes its recorded NADAC range and movement.

Current price$0.1804 per EA
All-time high$1.8437 (Mar 14, 2018)
All-time low$0.1722 (Jul 17, 2024)
52-week high$0.2197
52-week low$0.1796
Median price$0.6555
Average price$0.7776
Largest weekly change+69.2% (May 17, 2023)
Weeks tracked465
Tracking sinceSep 27, 2017

Price History

1W

-0.8%

1M

-0.8%

3M

+0.0%

6M

-7.4%

1Y

-17.5%

3Y

-47.0%

5Y

-79.2%

All

-90.2%

Generic Alternatives

No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the POTASSIUM CITRATE market page.

Lowest-Cost Alternatives

No alternatives available

No alternatives found with the same active ingredient and strength in a comparable dosage form.

Frequently asked questions

What is the NADAC price of POTASSIUM CITRATE ER 15 MEQ TB?

The current National Average Drug Acquisition Cost (NADAC) for POTASSIUM CITRATE ER 15 MEQ TB, manufactured by Strides Pharma Inc., is $0.1804 per EA (NDC 42543040801), effective Aug 19, 2026.

How has the price of POTASSIUM CITRATE ER 15 MEQ TB changed over time?

Over the history we have for it, the NADAC for POTASSIUM CITRATE ER 15 MEQ TB has declined 90.2%. It has been tracked across 465 weekly CMS publications since Sep 27, 2017.

What are the highest and lowest recorded NADAC prices for POTASSIUM CITRATE ER 15 MEQ TB?

Since Sep 27, 2017, the NADAC for POTASSIUM CITRATE ER 15 MEQ TB has ranged from a low of $0.1722 (Jul 17, 2024) to a high of $1.8437 (Mar 14, 2018), with a median of $0.6555 per EA.

Are there cheaper alternatives to POTASSIUM CITRATE ER 15 MEQ TB?

No other NADAC-published product currently shares the active ingredient and strength of POTASSIUM CITRATE ER 15 MEQ TB in a comparable dosage form, so no direct lower-cost alternative is listed.

Who manufactures POTASSIUM CITRATE ER 15 MEQ TB?

POTASSIUM CITRATE ER 15 MEQ TB (NDC 42543040801) is labeled by Strides Pharma Inc., and CMS classifies it as a generic product.